Fig. 2: Hazard ratios and cumulative incidences of NHL by breast cancer status.
From: Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study
A NHL, B DLBCL, C Follicular lymphoma, D Mature T/NK-cell lymphomas, and E ALCL. The cumulative incidences were calculated using Kaplan–Meier curves. Participants who developed breast cancer contributed person-time to the exposed group from the time of breast cancer development Unexposed person-time was contributed by participants who did not develop breast cancer and by participants who developed breast cancer prior to each comorbidity development. To reduce the potential impact of surveillance bias, we considered outcomes occurring in the first 31 days after breast cancer diagnosis as unexposed person-time. ALCL anaplastic large cell lymphoma, DLBCL Diffuse large B-cell lymphoma, NHL non-Hodgkin lymphoma.
